Cite
MLA Citation
Maria Cristina Campopiano et al.. “No difference in the outcome of metastatic thyroid cancer patients when using recombinant or endogenous TSH.” European journal of endocrinology, vol. 183, no. 4, 2020, pp. 411–417. http://access.bl.uk/ark:/81055/vdc_100120090681.0x000049